SAR 2.96
(6.47%)
Breakdown | 2023 | 2022 | 2021 |
---|---|---|---|
Operating Cash Flow | 5.29 Million | 8.17 Million | 1.44 Million |
Net Income | -126.16 Thousand | 4.46 Million | 6.04 Million |
Depreciation & Amortization | 10.77 Million | 5.13 Million | 3.92 Million |
Deferred income taxes | - | - | - |
Stock-based compensation | - | - | - |
Change in working capital | -6.77 Million | -1.97 Million | -8.82 Million |
Other non-cash items | 23.72 Million | 18.12 Million | 16.44 Million |
Investing Cash Flow | -8.68 Million | -5.34 Million | -7.36 Million |
Investments in PPE | -11.15 Million | -6.26 Million | -7.45 Million |
Acquisitions | 2.47 Million | 925 Thousand | 86.66 Thousand |
Investment purchases | - | - | - |
Sales/Maturities of investments | - | - | - |
Other Investing Activities | -8.68 Million | - | - |
Financing Cash Flow | 7.46 Million | -4.58 Million | 7.81 Million |
Debt repayment | -3.58 Million | -1.28 Million | -2.74 Million |
Dividends payments | - | - | - |
Common Stock Repurchased | - | - | - |
Common Stock Issuance | 20 Million | - | - |
Other Financing Activities | -1.99 Million | 3.09 Million | 8.55 Million |
Accounts receivables | -758.88 Thousand | -7.31 Million | -8.3 Million |
Accounts payables | - | - | - |
Inventory | - | - | - |
Other working capital | -6.01 Million | 5.33 Million | -527.35 Thousand |
Cash at beginning of period | 512.64 Thousand | 2.26 Million | 367.35 Thousand |
Cash at end of period | 4.59 Million | 512.64 Thousand | 2.26 Million |
Capital Expenditure | -11.15 Million | -6.26 Million | -7.45 Million |
Effect of forex changes on cash | - | - | - |
Net cash flow / Change in cash | 4.07 Million | -1.74 Million | 1.89 Million |
Free Cash Flow | -5.86 Million | 1.9 Million | -6 Million |
Breakdown | 2024 Q2 | 2023 FY | 2022 FY | 2021 FY |
---|---|---|---|---|
Operating Cash Flow | - | - | - | - |
Net Income | -73.93 Thousand | -126.16 Thousand | 4.46 Million | 6.04 Million |
Depreciation & Amortization | 5.6 Million | 10.77 Million | 5.13 Million | 3.92 Million |
Deferred income taxes | - | - | - | - |
Stock-based compensation | - | - | - | - |
Change in working capital | -6.57 Million | -6.77 Million | -1.97 Million | -8.82 Million |
Other non-cash items | 1.76 Million | 23.72 Million | 18.12 Million | 16.44 Million |
Investing Cash Flow | -943.98 Thousand | -8.68 Million | -5.34 Million | -7.36 Million |
Investments in PPE | -2.46 Million | -11.15 Million | -6.26 Million | -7.45 Million |
Acquisitions | 1.52 Million | 2.47 Million | 925 Thousand | 86.66 Thousand |
Investment purchases | - | - | - | - |
Sales/Maturities of investments | - | - | - | - |
Other Investing Activities | - | - | - | - |
Financing Cash Flow | -3.98 Million | 7.46 Million | -4.58 Million | 7.81 Million |
Debt repayment | -4.4 Million | -3.58 Million | -1.28 Million | -2.74 Million |
Dividends payments | - | - | - | - |
Common Stock Repurchased | - | - | - | - |
Common Stock Issuance | - | 20 Million | - | - |
Other Financing Activities | -8.38 Million | -1.99 Million | 3.09 Million | 8.55 Million |
Accounts receivables | -10.9 Million | -758.88 Thousand | -7.31 Million | -8.3 Million |
Accounts payables | -525.47 Thousand | - | - | - |
Inventory | - | - | - | - |
Other working capital | 4.85 Million | -6.01 Million | 5.33 Million | -527.35 Thousand |
Cash at beginning of period | 4.59 Million | 512.64 Thousand | 2.26 Million | 367.35 Thousand |
Cash at end of period | 381.05 Thousand | 4.59 Million | 512.64 Thousand | 2.26 Million |
Capital Expenditure | -2.46 Million | -11.15 Million | -6.26 Million | -7.45 Million |
Effect of forex changes on cash | - | - | - | - |
Net cash flow / Change in cash | -4.21 Million | 4.07 Million | -1.74 Million | 1.89 Million |
Free Cash Flow | -1.74 Million | -5.86 Million | 1.9 Million | -6 Million |
SSRSF
GARFIBRES
2907
ORPHA
GOLDIAM
LEE